Recombinant PCSK9 (Bococizumab Biosimilar) 抗体
The Mammalian Cells 单克隆 anti-PCSK9 (Bococizumab Biosimilar) antibody is suitable to detect PCSK9 (Bococizumab Biosimilar) in samples from 人. It has been validated for ELISA.
产品编号 ABIN7488036
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant PCSK9 (Bococizumab Biosimilar) 抗体 (ABIN7488036)
抗原
PCSK9 (Bococizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This PCSK9 (Bococizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb
-
产品特性
- Antibody Type: IgG2-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG2
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- PCSK9 (Bococizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
PF-04950615,RN-316
Bococizumab is a monoclonal antibody that was development by Pfizer targeting proprotein convertase subtilisin kexin type 9 (PCSK9). Bococizumab has been investigated for the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia. -
CAS-编号
- 1407495-02-6
抗原
-
You are here:
